Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea … Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NASDAQ
IPO Date: August 11, 2009
Headquarters: 1600 West End Avenue, Nashville, TN, United States, 37203
Founder-Led: Yes — A J Kazimi (Chairman/CEO/Founder)
Key Metrics
Current Price
$5.86
Market Cap
$82.6M
Float
8.8M
Shares Outstanding
15.0M
P/E (Forward)
50.00
Price/Sales (TTM)
1.97
vs. Analyst Target
+45.1% to analyst PT
Profit Margin
-17.60%
Operating Margin (TTM)
-34.27%
Revenue (TTM)
$41.9M
Dividend Rate
None
Analyst Target Price
$8.50 (1 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$37.4M
-$3.3M
$28.8M
-$1.6M
2021
$36.0M
-$3.5M
$27.2M
-$857,833
2022
$42.0M
-$5.6M
$32.9M
$332,919
2023
$39.6M
-$6.3M
$33.5M
$2.5M
2024
$37.9M
-$6.5M
$31.3M
$182,422
2025
$44.5M
-$2.8M
$37.9M
$2.5M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$10.8M
-$740,740
Sep 2025
$8.3M
-$1.9M
Dec 2025
$13.7M
-$1.4M
Mar 2026
$9.1M
-$3.1M
Ownership & Float
Insider Ownership
41.6%
Institutional Ownership
18.5%
Short Float
6.0%
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$4.29
Near-term / short-term trend
Weekly
40-Week SMA
$3.63
Medium-term trend
Weekly
80-Week SMA
$3.68
Cyclical trend (business cycle)
Weekly
200-Week SMA
$2.59
Secular trend (multi-year)
Monthly
10-Month SMA
$3.78
Near-term monthly trend
Monthly
20-Month SMA
$3.53
Medium-term monthly trend
Monthly
40-Month SMA
$2.62
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$3.30
support
7.28x
0 months ago
$2.30
support
2.96x
4 months ago
$2.20
support
4.11x
14 months ago
$1.40
support
9.49x
16 months ago
$1.20
support
6.26x
17 months ago
Historical Earnings Reactions (68 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.40%
0.00%
45.59%
10.76%
-22.16%
1 Day
-1.13%
-0.66%
41.18%
15.38%
-19.87%
1 Week
-3.09%
-1.93%
33.82%
21.68%
-32.75%
2 Weeks
-2.98%
-3.09%
39.71%
21.90%
-38.86%
1 Month
-0.88%
-0.89%
40.30%
101.67%
-32.31%
Next earnings: July 24, 2026 (57 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-1.0%
35.3%
17
Feb
7.3%
41.2%
17
Mar
-4.7%
29.4%
17
Apr
-1.7%
29.4%
17
May
-2.9%
50.0%
16
Jun
-1.3%
50.0%
16
Jul
1.0%
50.0%
16
Aug
-3.3%
43.8%
16
Sep
0.9%
47.1%
17
Oct
-2.6%
47.1%
17
Nov
5.5%
58.8%
17
Dec
7.6%
41.2%
17
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.19%
42.9%
790
Tuesday
0.42%
45.8%
869
Wednesday
0.07%
44.1%
866
Thursday
-0.01%
46.4%
850
Friday
-0.03%
45.5%
847
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 18.5%
Insider Transactions — Smart Summary
Total insider ownership: 41.6%
Founder-led management: A J Kazimi (Chairman/CEO/Founder)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cumberland Pharmaceuticals Inc
(CPIX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.